Literature DB >> 15341999

Heterologous immunity and homeostatic proliferation as barriers to tolerance.

Devon K Taylor1, David Neujahr, Laurence A Turka.   

Abstract

The different threshold of activation for memory T cells compared to that of naïve T cells makes them resistant to immunomodulation, thus representing a barrier to tolerance. Recently it has been demonstrated that homeostatic proliferation and heterologous immunity represent two naturally occurring and distinct processes that can generate memory T cells. Homeostatic proliferation refers to the process by which, in a lymphodeficient host, normal T cells 'spontaneously' proliferate in response to self-MHC-peptide complexes. Heterologous immunity refers to a process in which a response to one or more infectious agents generates effector/memory T cells with cross-reactive specificities. Recent new studies have defined the importance of these processes in transplantation models and implicated strategies to induce transplantation tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341999     DOI: 10.1016/j.coi.2004.07.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  28 in total

1.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

2.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

3.  Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT.

Authors:  Alwi M Shatry; Derry C Roopenian; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

4.  Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes.

Authors:  Linda M Stephenson; Brian C Miller; Aylwin Ng; Jason Eisenberg; Zijiang Zhao; Ken Cadwell; Daniel B Graham; Noboru N Mizushima; Ramnik Xavier; Herbert W Virgin; Wojciech Swat
Journal:  Autophagy       Date:  2009-07-10       Impact factor: 16.016

5.  Differential requirement of CD27 costimulatory signaling for naïve versus alloantigen-primed effector/memory CD8+ T cells.

Authors:  K Yamaura; O Boenisch; T Watanabe; T Ueno; V Vanguri; J Yang; K Tanaka; I Guleria; J Borst; Y Zhai; J W Kupiec-Weglinski; N Najafian
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

Review 6.  Cross-immune tolerance: conception and its potential significance on transplantation tolerance.

Authors:  Yong Zhao; Xianchang Li
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

Review 7.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

8.  Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.

Authors:  M K Nelsen; K S Beard; R J Plenter; R M Kedl; E T Clambey; R G Gill
Journal:  Am J Transplant       Date:  2017-02-21       Impact factor: 8.086

Review 9.  Memory T-cell-specific therapeutics in organ transplantation.

Authors:  Andrew J Page; Mandy L Ford; Allan D Kirk
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

10.  OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.

Authors:  Daniel Hirschhorn-Cymerman; Gabrielle A Rizzuto; Taha Merghoub; Adam D Cohen; Francesca Avogadri; Alexander M Lesokhin; Andrew D Weinberg; Jedd D Wolchok; Alan N Houghton
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.